210 related articles for article (PubMed ID: 22583827)
1. Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4.
Gomes M; Coelho A; Araújo A; Teixeira AL; Catarino R; Medeiros R
Gene; 2012 Aug; 504(1):111-5. PubMed ID: 22583827
[TBL] [Abstract][Full Text] [Related]
2. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
3. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
4. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
Farjadfar A; Mojtahedi Z; Ghayumi MA; Erfani N; Haghshenas MR; Ghaderi A
Acta Oncol; 2009; 48(7):971-6. PubMed ID: 19642044
[TBL] [Abstract][Full Text] [Related]
6. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
[TBL] [Abstract][Full Text] [Related]
7. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study.
Rafrafi A; Chahed B; Kaabachi S; Kaabachi W; Maalmi H; Hamzaoui K; Sassi FH
Hum Immunol; 2013 Oct; 74(10):1368-74. PubMed ID: 23831257
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
10. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Interleukin-4 Genotypes to Lung Cancer Risk in Taiwan.
Chang WS; Wang SC; Chuang CL; Ji HX; Hsiao CL; Hsu CM; Tsai CW; Liu SP; Hsu PC; Lo YL; Bau DT
Anticancer Res; 2015 Nov; 35(11):6297-301. PubMed ID: 26504066
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer.
Lee YL; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Shih CM
Lung Cancer; 2011 Aug; 73(2):147-52. PubMed ID: 21292343
[TBL] [Abstract][Full Text] [Related]
14. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
[TBL] [Abstract][Full Text] [Related]
15. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
[TBL] [Abstract][Full Text] [Related]
16. [Association of susceptibility to chronic rhinosinusitis with genetic polymorphisms of IL-4 and IL-10].
Zhang ML; Ni PH; Cai CP; Chen NJ; Wang SL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):212-7. PubMed ID: 22805022
[TBL] [Abstract][Full Text] [Related]
17. Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer.
Kuo WH; Shih CM; Lin CW; Cheng WE; Chen SC; Chen W; Lee YL
Transl Res; 2012 Jan; 159(1):42-50. PubMed ID: 22153809
[TBL] [Abstract][Full Text] [Related]
18. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
[TBL] [Abstract][Full Text] [Related]
19. Association between the polymorphisms of IL-4 gene promoter (-590C>T), IL-13 coding region (R130Q) and IL-16 gene promoter (-295T>C) and allergic asthma.
Hosseini-Farahabadi S; Tavakkol-Afshari J; Rafatpanah H; Farid Hosseini R; Khaje Daluei M
Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):9-14. PubMed ID: 17303923
[TBL] [Abstract][Full Text] [Related]
20. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
